LADENBURG THALMANN FINANCIAL SERVICES INC. - IMMUNOCELLULAR THERAPEUTICS ownership

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of IMMUNOCELLULAR THERAPEUTICS
ValueSharesWeighting
Q2 2017$0450.0%0.00%
Q1 2017$045
-35.7%
0.00%
Q4 2016$0700.00%
Other shareholders
IMMUNOCELLULAR THERAPEUTICS shareholders Q2 2024
NameSharesValueWeighting ↓
WEDBUSH SECURITIES INC 86,530$22,0000.00%
Virtu Financial LLC 124,195$32,0000.00%
BARCLAYS PLC 50$00.00%
WELLS FARGO & COMPANY/MN 250$00.00%
UBS Group AG 32,270$8,0000.00%
Tradewinds Capital Management, LLC 200$00.00%
Rehmann Capital Advisory Group 69$18,0000.00%
IFP Advisors, Inc 95$00.00%
Jacobi Capital Management LLC 125$00.00%
Certified Advisory Corp 20$00.00%
View complete list of IMMUNOCELLULAR THERAPEUTICS shareholders